This inventor holds 4 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignees: Beijing University of Technology, Murdoch University, The University of Western Australia. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Clayton, AU (2022 - 2023)
- Ashburton, AU (2024)
Company Filing History:
3 out of 389 
3 out of 11 
1 out of 109 
Years Active: 2022-2026
Title: The Innovations of Merlin Christopher Thomas
Introduction
Merlin Christopher Thomas is an accomplished inventor based in Clayton, Australia. He has made significant contributions to the field of receptor biology, particularly in relation to the Receptor for Advanced Glycation End-products (RAGE). With a total of three patents to his name, Thomas has developed innovative methods and compounds that have the potential to impact medical research and therapeutic applications.
Latest Patents
Thomas's latest patents include groundbreaking work on screening assays and modulators of RAGE activity. One of his notable patents describes a method for screening candidate agents that can modulate RAGE activity induced by an active co-located GPCR. This method involves contacting a RAGE polypeptide with a GPCR polypeptide in the presence of a candidate agent, allowing for the detection of modulation effects on RAGE activation. Another significant patent focuses on an isolated or purified AON for modifying pre-mRNA splicing in RAGE, which aims to modulate the splicing of the RAGE gene transcript.
Career Highlights
Throughout his career, Thomas has worked with prestigious institutions such as Beijing University of Technology and Murdoch University. His research has contributed to a deeper understanding of RAGE and its implications in various diseases, showcasing his commitment to advancing scientific knowledge.
Collaborations
Thomas has collaborated with notable colleagues, including Raelene Jane Pickering and Carlos Rosado. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.
Conclusion
Merlin Christopher Thomas is a prominent inventor whose work on RAGE has the potential to influence future therapeutic strategies. His innovative patents and collaborations reflect his dedication to advancing the field of receptor biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile